These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1760147)

  • 1. In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes.
    Evans RC; Holmes CJ
    Blood Purif; 1991; 9(2):92-101. PubMed ID: 1760147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
    Kumano K; Yokota S; Nanbu M; Sakai T
    Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrogen transfer across high- and low-flux hemodialysis membranes.
    Weber V; Linsberger I; Rossmanith E; Weber C; Falkenhagen D
    Artif Organs; 2004 Feb; 28(2):210-7. PubMed ID: 14961961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
    Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
    Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood components influence cytokine induction by bacterial substances.
    Schindler R; Eichert F; Lepenies J; Frei U
    Blood Purif; 2001; 19(4):380-7. PubMed ID: 11574734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate.
    Jaber BL; Gonski JA; Cendoroglo M; Balakrishnan VS; Razeghi P; Dinarello CA; Pereira BJ
    Blood Purif; 1998; 16(4):210-9. PubMed ID: 9736790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial challenge of NISSHO ultrafilter ETF 609: results of in vitro testing.
    Krautzig S; Lonnemann G; Shaldon S; Koch KM
    Artif Organs; 1996 Jul; 20(7):798-800. PubMed ID: 8828771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced cytokine induction and removal of complement products with synthetic hemodialysis membranes.
    Schindler R; Ertl T; Beck W; Lepenies J; Boenisch O; Oppermann M; Kaspar E; Frei U
    Blood Purif; 2006; 24(2):203-11. PubMed ID: 16373999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of endotoxin antibody in long-term dialysis patients.
    Yamagami S; Adachi T; Sugimura T; Wada S; Kishimoto T; Maekawa M; Yoshimura R; Niwa M; Terano Y; Shaldon S
    Int J Artif Organs; 1990 Apr; 13(4):205-10. PubMed ID: 2115504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of plasma in the transfer of Escherichia coli cytokine-inducing substances across high-flux cellulosic membranes.
    Holmes CJ; Evans RC; Henderson LW
    J Lab Clin Med; 1994 Dec; 124(6):782-8. PubMed ID: 7798790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of dialysis membrane as an endotoxin transfer barrier: geometry, morphology, and permeability.
    Henrie M; Ford C; Andersen M; Stroup E; Diaz-Buxo J; Madsen B; Britt D; Ho CH
    Artif Organs; 2008 Sep; 32(9):701-10. PubMed ID: 18684209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention of cytokine-inducing substances inside high-flux dialyzers.
    Lufft V; Mahiout A; Shaldon S; Koch KM; Schindler R
    Blood Purif; 1996; 14(1):26-34. PubMed ID: 8718562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis.
    Ureña P; Herbelin A; Zingraff J; Lair M; Man NK; Descamps-Latscha B; Drüeke T
    Nephrol Dial Transplant; 1992; 7(1):16-28. PubMed ID: 1316577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria.
    Lonnemann G; Behme TC; Lenzner B; Floege J; Schulze M; Colton CK; Koch KM; Shaldon S
    Kidney Int; 1992 Jul; 42(1):61-8. PubMed ID: 1635355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro studies of cytokine-inducing substance (CIS) transfer across haemodialysis membranes--a cautionary note.
    Holmes CJ; Evans RC
    Nephrol Dial Transplant; 1995; 10(1):139. PubMed ID: 7724015
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dialysate and biocompatibility in hemodialysis].
    Berland Y
    Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
    Bigazzi R; Atti M; Baldari G
    Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes.
    Lonnemann G; Schindler R; Lufft V; Mahiout A; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1995; 10(2):207-11. PubMed ID: 7753454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of the Limulus amebocyte lysate-reactive substances flushed from cellulose hemodialysis membranes].
    Strokov AG; Baeva LB; Levitskiĭ ER; Tiagny-Riadno LI
    Urol Nefrol (Mosk); 1993; (3):41-4. PubMed ID: 7941162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.